首页> 外文期刊>British Journal of Clinical Pharmacology >A single dose of methadone inhibits cytochrome P-4503A activity in healthy volunteers as assessed by the urinary cortisol ratio.
【24h】

A single dose of methadone inhibits cytochrome P-4503A activity in healthy volunteers as assessed by the urinary cortisol ratio.

机译:通过尿皮质醇比例评估,单剂量美沙酮可抑制健康志愿者体内的细胞色素P-4503A活性。

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS: To examine the effect of a single oral dose of methadone on cytochrome P450 (CYP) 3A activity using the urinary 6beta-hydroxycortisol to cortisol ratio (UCR) as a marker of CYP3A activity. METHODS: A single oral dose (0.2 mg kg-1) of rac-methadone was administered to eight healthy female volunteers. Frequent blood samples and all urine over seven time periods was collected for 96 h following dosing. The UCR and the concentration of the major CYP3A metabolite of methadone, EDDP, were measured in urine. Methadone enantiomer concentrations were determined in plasma and urine. All quantifications were performed by validated high performance liquid chromatography assays. RESULTS: In all volunteers a significant decline of the UCR from immediately predose values was observed at the 4-8 and 8-12 h collection periods (P < 0.05, 95% CI for the differences: 0.4,16 and 0.6,16, respectively) with a return to immediately predose values after 2-3 days, suggesting methadone was an inhibitor of CYP3A. The UCR was found to be significantly correlated with the amount of EDDP excreted in the urine and with the area under the plasma concentration vs time profile for total (R + S) methadone, supporting in vitro data that CYP3A is primarily responsible for EDDP formation and has a significant influence on methadone disposition. CONCLUSIONS: Methadone appears to be a CYP3A inhibitor in vivo following a single oral dose and measurements of the urinary cortisol ratio appear to be a useful index to follow this inhibition.
机译:目的:使用尿液中的6β-羟基皮质醇与皮质醇比率(UCR)作为CYP3A活性的标志物,研究单次口服美沙酮对细胞色素P450(CYP)3A活性的影响。方法:对八名健康女性志愿者进行一次口服口服消旋美沙酮治疗(0.2 mg kg-1)。给药后96小时,收集七个时间段内的频繁血液样本和所有尿液。测定尿液中的UCR和美沙酮主要CYP3A代谢物EDDP的浓度。测定血浆和尿液中美沙酮对映体的浓度。所有定量均通过经过验证的高效液相色谱法进行。结果:在所有志愿者中,在收集的4-8和8-12 h期间,UCR均比立即用药前的值显着下降(差异分别为P <0.05、95%CI:0.4、16和0.6、16 ),并在2-3天后立即恢复到给药前值,提示美沙酮是C​​YP3A的抑制剂。发现UCR与尿中排泄的EDDP量以及血浆浓度对总美沙酮(R + S)的时间分布下的面积显着相关,支持体外数据表明CYP3A主要负责EDDP的形成和对美沙酮的处置有重要影响。结论:在单次口服剂量后,美沙酮似乎是体内的CYP3A抑制剂,测定尿皮质醇的比例似乎是遵循该抑制作用的有用指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号